Page last updated: 2024-11-03

riluzole and HMN (Hereditary Motor Neuropathy) Proximal Type I

riluzole has been researched along with HMN (Hereditary Motor Neuropathy) Proximal Type I in 3 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosboom, W1
Vrancken, AF3
van den Berg, LH3
Wokke, J1
Iannaccone, ST3
Wadman, RI2
Bosboom, WM2
Wokke, JH2
van der Pol, WL1

Reviews

3 reviews available for riluzole and HMN (Hereditary Motor Neuropathy) Proximal Type I

ArticleYear
Drug treatment for spinal muscular atrophy type I.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Child, Preschool; Humans; Infant; Neuroprotective Agents; Randomized Controlled Trials as Topic; Ril

2009
Drug treatment for spinal muscular atrophy type I.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Child, Preschool; Humans; Infant; Neuroprotective Agents; Randomized Controlled Trials as Topic; Ril

2011
Drug treatment for spinal muscular atrophy type I.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Child, Preschool; Disease Progression; Humans; Infant; Neuroprotective Agents; Randomized Controlled

2012